Impaired health-related quality of life in Addison's disease - Impact of replacement therapy, comorbidities and socio-economic factors

Clinical Endocrinology

Volumn 81, Issue 4, 2014, Pages 511-518

  Kluger, Nicolas ^a   Matikainen, Niina ^a   Sintonen, Harri ^b   Ranki, Annamari ^a   Roine, Risto P ^c   Schalin Jäntti, Camilla ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PREDNISOLONE;

ADDISON DISEASE; ADULT; AGE DISTRIBUTION; ARTICLE; AUTOIMMUNE DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEALTH CARE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; QUALITY OF LIFE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SUBSTITUTION THERAPY; AGED; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADDISON DISEASE; ADULT; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908090373     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12484     Document Type: Article

References (34)

1. Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A. et al. (2006) Premature mortality in patients with Addison's disease: a population-based study. Journal of Clinical Endocrinology and Metabolism, 91, 4849-4853.
2. Løva˚s, K., Loge, J.H. & Husebye, E.S. (2002) Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology, 56, 581-588.
3. Alonso, N., Granada, M.L., Lucas, A. et al. (2004) Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters. Journal of Endocrinological Investigation, 27, 449-454.
4. Hahner, S., Loeffler, M., Fassnacht, M. et al. (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. Journal of Clinical Endocrinology and Metabolism, 92, 3912-3922.
5. Bleicken, B., Hahner, S., Loeffler, M. et al. (2010) Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clinical Endocrinology, 72, 297-304.
6. Ekman, B., Bachrach-Lindström, M., Lindström, T. et al. (2012) A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clinical Endocrinology, 77, 18-25.
7. Meyer, G., Hackemann, A., Penna-Martinez, M. et al. (2013) What affects the quality of life in autoimmune Addison's disease? Hormone and Metabolic Research, 45, 92-95.
8. Thomsen, A.F., Kvist, T.K., Andersen, P.K. et al. (2006) The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology, 31, 614-622.
9. Gurnell, E.M., Hunt, P.J., Curran, S.E. et al. (2008) Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism, 93, 400-409.
10. Erichsen, M.M., Løva˚s, K., Fougner, K.J. et al. (2009) Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. European Journal of Endocrinology, 160, 233-237.
11. Arlt, W. (2009) The approach to the adult with newly diagnosed adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 94, 1059-1067.
12. Forss, M., Batcheller, G., Skrtic, S. et al. (2012) Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocrine Disorders, 13, 8.
13. Peters, C.J., Hill, N., Dattani, M.T. et al. (2013) Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy. Clinical Endocrinology, 78, 347-351.
14. Neary, N. & Nieman, L. (2010) Adrenal insufficiency: etiology, diagnosis and treatment. Current Opinion in Endocrinology Diabetes & Obesity, 17, 217-223.
15. Husebye, E.S., Allolio, B., Arlt, W. et al. (2014) Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. Journal of Internal Medicine, 275, 104-115.
16. Saarni, S.I., Härkänen, T., Sintonen, H. et al. (2006) The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Quality of Life Research, 15, 1403-1414.
17. Kluger, N., Jokinen, M., Krohn, K. et al. (2013) What is the burden of living with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in 2012? A health-related quality-of-life assessment in Finnish patients. Clinical Endocrinology, 79, 134-141.
18. Sintonen, H. (2001) The 15D instrument of health-related quality of life: properties and applications. Annals of Medicine, 33, 328-336.
19. Alanne, S. (2011) Subjectively Significant Change in the Measurement of Health-Related Quality of Life. University of Eastern Finland., Faculty of Social Sciences and Business Studies, Department of Health Policy and Management, 1-64,
20. Aromaa, A. & Koskiken, S. (2004) Health and Functional Capacity in Finland. Baseline results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute, Helsinki.
21. Aalto, A.M., Aro, A.R. & Teperi, J. (1999) RAND-36 as a measure of Health-Related Quality of Life. Reliability, construct validity and reference values in the Finnish general population [in Finnish; English summary]. (National Research and Development Center for Welfare and Health, Research Reports 101). Gummerus, Helsinki, Saarijärvi.
22. Hays, R.D., Sherbourne, C.D. & Mazel, R.M. (1993) The RAND 36-Item Health Survey 1.0. Health Economics, 2, 217-227.
23. Wong, V., Yan, T., Donald, A. et al. (2004) Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. Clinical Endocrinology (Oxf), 61, 131-137.
24. Ross, I.L., Levitt, N.S., Van der Walt, J.S. et al. (2013) Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement. Hormone and Metabolic Research, 45, 62-68.
25. Øksnes, M., Bensing, S., Hulting, A.L. et al. (2012) Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL. Journal of Clinical Endocrinology and Metabolism, 97, 568-576.
26. Haapamäki, J., Turunen, U., Roine, R.P. et al. (2009) Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Quality of Life Research, 18, 961-969.
27. Laas, K., Roine, R., Räsänen, P. et al. (2009) Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatology International, 29, 267-273.
28. Løva˚s, K., Gebre-Medhin, G., Trovik, T.S. et al. (2003) Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. Journal of Clinical Endocrinology and Metabolism, 88, 1112-1118.
29. Libè, R., Barbetta, L., Dall'Asta, C. et al. (2004) Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. Journal of Endocrinological Investigation, 27, 736-741.
30. Niedzwiedz, C.L., Katikireddi, S.V., Pell, J.P. et al. (2012) Life course socio-economic position and quality of life in adulthood: a systematic review of life course models. BMC Public Health, 9, 628.
31. van Haastregt, J.C., de Witte, L.P., Terpstra, S.J. et al. (1994) Membership of a patients' association and well-being. A study into the relationship between membership of a patients' association, fellow-patient contact, information received, and psychosocial well-being of people with a neuromuscular disease. Patient Education and Counseling, 24, 135-148.
32. Selinger, C.P., Lal, S., Eaden, J. et al. (2013) Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease. Journal of Crohn's and Colitis, 7, e214-e218.
33. Pelttari, H., Sintonen, H., Schalin-Jäntti, C. et al. (2009) Health-related quality of life in long-term follow-up of patients with cured TNM Stage I or II differentiated thyroid carcinoma. Clinical Endocrinology, 70, 493-497.
34. Løva˚s, K., Curran, S., Oksnes, M. et al. (2010) Development of a disease-specific quality of life questionnaire in Addison's disease. Journal of Clinical Endocrinology and Metabolism, 95, 545-551.